谷歌浏览器插件
订阅小程序
在清言上使用

Molecular Determinants of Response to Neoadjuvant Pembrolizumab Plus Chemotherapy in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer: Exploratory Analysis of the Open-Label, Multicohort Phase 1b KEYNOTE-173 Study

Breast Cancer Research(2025)

引用 0|浏览2
关键词
Immunohistochemistry,Triple-negative breast cancer,Tumor microenvironment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要